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Abstract We have constructed a retroviral expression vector 
for the mammalian ribonucleotide reductase R2 component. 
Stable infectants, which express a myc epitopo tagged R2 protein 
from the vector eDNA were obtained and described for the first 
time. Cells containing the recombinant protein exhibited 
increased ribonucleotide reductase activity, and were resistant 
to the antitumour agent hydroxyurea, which targets the R2 
component of ribonucleotide reductase. Furthermore, a direct 
link between ferritin gene expression and R2 protein was 
observed, since cells containing vector expressed recombinant 
R2 protein exhibited Increased H-chain and L.chain ferritin gone 
expression. 
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1. Introduction 
Iron is required for the activities of proteins involved in 
DNA synthesis, electron transport and oxygen metabolism 
[1]. However, iron is insoluble under physiological conditions 
so that specialized proteins, the ferritins, are needed to main- 
tain it in an available form [1,2]. Ferritin is composed of 24 
subunits that are the products of ferritin (H)-chain and ferri- 
tin (L)-chain genes, and they can combine in different propor- 
tions to produce families of isoferritins that exhibit differences 
in synthesis and turnover ates, and in the ability to accept or 
release iron [!,2]. Ribonucleotide reductase consists of two 
non-identical subunits called R I and R2 in mammalian cells, 
and since this enzyme converts ribonucleotides to deoxyribo- 
nucleotides, it is essential for the synthesis of DNA [3,4]. A 
requirement of iron for DNA synthesis is due to an iron 
centre in the R2 protein. Treatment of cells with the antitu- 
mour agent, hydroxyurea, destabilizes the iron centre, and 
destroys a tyrosyl free radical in the R2 protein, resulting in 
a loss of enyzme activity and an inhibition of DNA synthesis 
and cell proliferation [5]. We have shown that cells selected 
for resistance to the cytotoxic effects of hyd,'oxyurea contain 
elevated levels of the R2 protein of ribonucleotide r ductase, 
which is rate-limiting for enzyme activity [3,4]. Interestingly, 
these drug resistant cells also showed increased ferritin gene 
expression, suggesting that ferritin plays an important role as 
a storage protein for detoxifying excess iron released from 
inactive R2, and/or as an intracellular reservoir for iron that 
is required for activation of the R2 protein [5,6]. However, 
hydroxyurea resistant cells contain changes in a variety of 
enzyme activities in addition to ribonucleotide r ductase (the 
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target for the drug) and ferritin, as we have demonstrated in 
previous tudies [3,4,6,7]. The R2 gone is frequently amplified 
in mammalian cells resistant to hydroxyurea, nd the elevated 
expression of genes like ornithine decarboxylase and a gone 
coding for a disulphide isomerase activity in these cells 
appears to be due to the co-amplification of these genes, 
which are located on the same chromosome close to the R2 
gone [6-9]. Furthermore, the selection of drug resistant cell 
lines in culture over several months can lead to additional 
non-specific hanges associated with these cell lines [7]. If 
there is a connection between ribonucleotide reductase and 
ferritin gone expression as previous studies suggest, then the 
expression of a recombinant R2 in mouse cells should elicit an 
accompanying elevation in ferritin gene expression in these 
cells. In the present study, we have taken this direct approach 
to test this important question, which does not suffer from the 
problems associated with selection of drug resistant mutant 
cell lines. We have constructed a retroviral expression vector 
for R2, and we have used it to investigate gone expression in 
cells soon after infection. 
2. Materials and methods 
2.1. Cell culture conditions 
NIH 3T3 mouse cells and a H-ras transfected cell line called 
CIRAS-I (or C-I) derived from mouse 10Tl/2 cells, were used in 
this study [10]. Cells were cultured in otominimai essential medium 
(Gibco, Grand Island, NY) supplemented with 10% calf serum (Fe- 
talclone Ill, Hyclone, Logan, UT) as previously reported [10]. The 
retroviral vector package lines ¥2, PA317, and their derivatives were 
maintained in Dulbecco's modified Eagle's medium (Gibco) contain- 
ing 10% calf serum and 0.45% glucose. Determinations of cell division 
times, and sensitivities to hydroxyurea cytotoxicity by estimating re- 
lative colony forming efliciencies, were carried out as described pre- 
viously [10,11]. 
2.2. Construction of the R2 expression vector 
The c.myc epitope-tagged mouse R2 cDNA was obtained by poly- 
merase chain reaction (PCR) using the 5'-primer CGCGGATCCGC- 
CA CCATGGAACAAAAGCTTATTTCTGAAGAAGACTTGATG- 
CTCTCCGTCCGCACC (where the Kozak sequence, a possible 
ribosomal binding signal [12], is in italics; the sequence encoding 
the human myc epitope is underlined; and the natural ATG initiation 
codon is in bold), and the Y-primer CGCGGATCCTTAGAAGT- 
CAGCATCCAAGG (where the termination codon is in bold). The 
PCR reaction contained, in a final volume of 100 ~tl, 200 ttM of each 
dNTP, 0.3 ~M of each primer, 100 ng of template DNA pcD-M2 [I 3], 
1.0 unit of Taq DNA polymerase and 1 × amplification buffer (Phar- 
macia Biotech, Uppsala, Sweden). Amplification was achieved by in- 
itial denaturation of the template DNA at 94°C for 2 rain, and then 
25 temperature cycles each consisting of 10 s denaturing at 94°C, 30 s 
annealing at 55°C and 1 min extension at 70°C. The PCR product was 
phenol: chloroform-extracted an  ethanol-precipitated. TheDNA was 
redissolved in 100 ~tl of I xTE buffer (10 mM Tris-HCI, pH 8.0 and 
I mM of EDTA) containing 5 ~tg of protease K (Boehringer-Mann- 
helm, Laval, Quebec) and incubated at 37°C for 30 min. The protease 
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Fig. I. Western blot analysis of myc epitope-tagged R2 protein. 
NIH 31"3 and Cl cells were infected with myc-R2 expression vector 
virus or pLXSH control vector virus, and selected for stable infec- 
rants to give the N3/mR2 and CI/mR2, or N3/SH and CI/SH cell 
lines, respectively. The positions and molecular weights of protein 
markers are shown on the right. 
K-treated DNA was again extracted with phenol:chloride and preci- 
pitated with ethanol. The DNA was digested with Xhol, agarose gel- 
purified and finally iigated into Xhol-digested and dephosphorylated 
pLXSH (kindly provided by A.D. Miller, Fred Hutchinson Cancer 
Center, Seattle) to generate the retroviral vector pSHImR2. The riga- 
tion product was electroporated into competent Escherichia coli 
DHS0¢ cells. Recombinant vector from transformed bacteria was 
screened by PCR using the primers described above. The authenticity 
and orientation of the vector R2 eDNA insert were confirmed by 
sequence analysis, using a sequencing kit (Gibco BRL, Burlington, 
Ontario). 
2.& Packagtmg ofretrovtral vector and preparation of stock 
Packaging was carried out using published procedures [13,14]. 
Briefly, column-purified vector DNA was initially transfected into 
¥2 cells by calcium phosphate precipitation [10]. Culture medium 
was changed 24 h later and collected after another 24 h incubation 
period. Following centdfulpttion to remove cells, I ml of the super- 
natant was used as viral stock to infect a second package line PA317. 
Permanent packaging cells were sd~ted from uninfected cells by 
8~owing the cells in medium containing 400148/ml hygromycin (Boeh- 
ringer-Mannheim). To prepare viral stock, cells from fresh mono- 
layers were split at a ratio of !: 10, and were added to medium minus 
hygromycin when they reached about 50% confluency. After 3 days 
incubation the medium was collected, centrifuged to remove cells and 
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was used as viral stock. The infectivity of viral stock was determined 
by titration on NIH 3T3 c-lls in the presence of hygromycin [13,14]. 
2.4. Western blot analysis of cell ~xpressed pitopic R2 
Western analysis was performed as previously described [5,6], using 
the anti-myc mouse monoclonal antibody, 9El0 (ATCC, Rockville, 
MD), and horseradish peroxidase-conjugated goat anti-mouse anti- 
body (Amersham, Mississauga, Ontario). Blotting was visualized 
with an enhanced chemiluminescence (ECL) Western blotting detec- 
tion system (Amersham) following the manufacturer's directions. 
2.5. Northern bY, qnalysis 
Total cellular R_~IA was extracted from logarithmically growing 
cells using a rapid RNA extraction kit (Stratagene, LaJolla, CA), 
by following the manufacturer's in tructions. Electrophoresis, 32p-la- 
belling of eDNA probes [5,6] and blotting procedures have been de- 
scribed [5,6,10]. Radioactivity on filters was detected by a phophor- 
imager (Molecular Dynamics Inc., Sunnyvale, CA), and quantitation 
was performed using Image Quant software (Molecular Dynamics, 
Inc.). 
2.6. Ribonucleotide reductase assay 
Logarithmically ~rowing cells were added to culture plates at about 
3x 10 ° cells/150 mm plate, cultured for 24 h, removed with trypsin, 
collected by centrifugation, washed with cold buffer, and lysed in 100 
141 phosphate-buffered saline, pH 7.2 containing I mM dithiothreitol 
and I mM of the protease inhibitor AEBSF (Calbiochem, San Fran- 
cisco, CA), by three cycles of freeze-thawing. Following centrifuga- 
tion, the supernatant was used for enzyme activity assays using 
[14C]CDP (Moravek Biomedical, Brea, CA) as we have previously 
described [6,15]. 
3, Results and discussion 
3.1. Recombinant R2 expression 
A retroviral vector.mediated xpression system was u~ed to 
obtain high infection efficiency and to achieve stable expres- 
sion of the R2 protein in mammalian cells. To distinguish the 
vector gene product from the endogenous R2, we added a 
human c-myc epitope coding for 10 amino acids plus methio- 
nine to the 5'-end of the R2 eDNA. In addition, to enhance 
binding of the recombinant R2 mRNA to ribosomes and to 
increase the efficiency of protein synthesis, we placed a typical 
Kozak sequence upstream of the coding region [12]. This fu- 
sion eDNA was inserted into the retrovirai vector pLXSH to 
generate the R2 viral expression vector pSH/mR2. NIH 3T3 
and CI cells were infected with ".."is vector, or a control vector 
which is identical to pSH/mR2 6at lacks the myc-R2 fusion 
eDNA, and stable infectants were selected in the presence of 
hygromycin. The myc-R2 vector infected cells were called N3/ 
mR2 (NIH 3T3 cells) and CI/mR2 (CI cells), and the corre- 
sponding control vector infected populations were called N3/ 
SH (NIH 3T3 cells) and CI/SH (CI cells). As shown in Fig. 1, 
the anti-myc monoclonal antibody detected a protein band of 
45 kDa corresponding to the R2 protein in myc-R2 vector 
infected cells [4-6], providing an example of stably expressed 
R2 eDNA in mammalian cells. 
Table ! 
Sensitivity to hydroxyurea 
Hydroxyurea (IzM) Relative colony formation el~ciency 
N3/SH N31mR2 CI/SH CI/mR2 
200 1.0× 10 -3 3.8× 10 -2 2.1 x 10 -~ i.4x l0 -2 
300 <5x 10 -4 2.2X 10 -~ 5.6x 10 -4 3.9x 10 -3 
400 <1X |0 -s 7,0X 10 -4 4.0X 10 -5 !.1X 10 -a 
600 ND ND <1X 10 -5 1.0× 10 -4 
All analyses were performed on duplicate dishes, with values varying by less than ! 5%. ND = not determined. 
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Fig. 2. Northern blot analysis of ferritin gone e:~pression. Total cel- 
lular RNA was extracted from logarithmically growing cells. H- and 
L-ferritin probes [5,6] were prepared by nick.translation using 
[ot-a2P]dCTP. The 13-actin cDNA fragment was labelled with 
[a-a2P]dCTP by random primer labelling and used as a loading con- 
trol. Numbers how the relative amounts of mRNA from each pair 
of test and control ines as analyzed with a phosphorimager. 
To determine if the myc-R2 protein is biologically active, 
the sensitivity of cells to the cytotoxic effects of hydroxyurea 
was evaluated in colony forming assays. In drug resistance 
studies, it has been shown that increased levels of active R2 
leads to reduced sensitivity to hydroxyurea, which works by 
destabilizing the iron centre in the R2 protein [5,6]. Table 1 
shows that the drug sensitivities of N3/mR2 and CIImR2 cells 
were markedly reduced when compared to control cells in- 
fected with vector alone. Since R2 is limiting for enzyme ac- 
tivity in proliferating cells [4], an increase in active R2 protein 
should also result in a modest but consistent elevation in 
ribonucleotide reductase activity in myc.R2 expressing cells 
when compared to cells infected with the control vector. Table 
2 shows that this is correct, since both N3/mR2 and CIImR2 
cells exhibited 2-3 fold increases in ribonucleotide reductase 
activity when compared to N3/SH and CI/SH cells. This in- 
crease in enzyme activity did not appear to affect the prolif- 
erative abilities of the N31mR2 or CIImR2 cells since their cell 
doubling times were about the same as N3/SH or CIISH cells 
(Table 1). 
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Fig. 3. Western blot analysis of the ferritin proteins. Rabbit polyclo- 
nal antibody, which recognizes the 18 and 24.5 kDa ferHtin subunits 
(Boehringer Mannheim, Laval, Quebec), was used as previously de- 
scribed [5,6]. The positions of the subunits are indicated on the left. 
3.2. Ferritin gone ext,,ession 
By using the R2 viral expression vector that we have con- 
structed we have obtained cells that have increased ribonu- 
cleotide reductase activity due to elevated levels of active R2 
protein, and this was achieved without selecting for resistance 
to drugs like hydroxyurea, that target the R2 subunit of the 
enzyme. We were interested in determining whether the ele- 
vated levels of R2 would be accompanied by increased expres- 
sion of the ferritin genes, as has been observed with cell lines 
selected for resistance to hydroxyurea [4-6]. Fig. 2 shows that 
both H-chain and L-chain ferritin mRNAs are elevated in 
cells expressing the recombinant R2. Quantitated analysis 
showed that H-chain ferritin gone expression in N31mR2 
and CIImR2 cells was 2.8 and 3.2 times greater than the 
expression observed in N31SH and CIISH cells, respectively. 
Also, expression of the L-chain ferritin gene was increased in 
N3/mR2 and CllmR2 cells by 1.9 and 2.3 times when com- 
pared to the results obtained with N3/SH and CI/SH cells, 
respectively. The increases in ferritin H aad L mRNA levels in 
N31mR2 and CIImR2 cells were also accompanied by in- 
creases in H and L ferritin protein levels in these cells, when 
compared to their respective control populations (Fig. 3). 
In total, the results of this study demonstrate hat ferritin 
gone expression is tightly linked to the presence of R2 protein. 
This is likely due to the iron centre of the protein which is 
required for enzyme activity, since a loss of iron destroys 
ribonucleotide reductase activity preventing DNA synthesis 
and cell proliferation [4]. Free iron is extremely toxic to cells 
[1,2]. Therefore, during the synthesis of R2 protein, it is rea- 
sonable to expect a requirement for ferritin-associated iron to 
generate an active R2 protein, and during R2 protein turnover 
it would be essential to sequester excess iron released uring 
this process. These findings also indicate an important role for 
Table 2 
Ribonucleotide r ductase activity and cell doubling times 
Cell line CDP reduction ~(fold increase) 
Cell doubling time b 
N31SH 0.83 + 0.08 16.7 
N31mR2 !.71 +0.11 (2.06)" 17.3 
C 11SH 0.92 + 0.11 12.9 
CI/mR2 2.70 + 0.22 (2.93) c 12.2 
aEnzyme activity is expressed as nmol of CDP reducedlmg of protein per h. Results in this column represent average +SE of three independent 
experiments. 
bCell doubling times are expressed as the average values obtained from two independent experiments. 
CNumber in parentheses indicates the fold increase in enzyme activity compared to the cortrol values. 
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ferritin in the regulation of DNA synthesis, which occurs 
through its link to a key rate-limiting step in the synthesis 
of DNA, ribonu¢leotide reductase [3,4]. 
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